Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infectedc patients from a southern Brazilian population

A cross-sectional study was carried out in order to describe the epidemiological, immunological and virological characteristics, and the disease progression of hepatitis C virus (HCV)/human immunodeficiency virus type 1 (HIV-1)- co-infected patients from a southern Brazilian population. Of 778 HIV-1...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular medicine 2008-03, Vol.21 (3), p.387-395
Main Authors: Vissoci Reiche, Edna, Bonametti, Ana, Morimoto, Helena, Morimoto, Arilson, Wiechemann, Susana, Matsuo, Tiemi, Vissoci Reiche, Fernando, Vogler, Ingridt
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 395
container_issue 3
container_start_page 387
container_title International journal of molecular medicine
container_volume 21
creator Vissoci Reiche, Edna
Bonametti, Ana
Morimoto, Helena
Morimoto, Arilson
Wiechemann, Susana
Matsuo, Tiemi
Vissoci Reiche, Fernando
Vogler, Ingridt
description A cross-sectional study was carried out in order to describe the epidemiological, immunological and virological characteristics, and the disease progression of hepatitis C virus (HCV)/human immunodeficiency virus type 1 (HIV-1)- co-infected patients from a southern Brazilian population. Of 778 HIV-1-infected individuals enrolled in the study from September 2001 to December 2003, and followed up until June 2004, 757 were tested for anti-HCV antibodies. Of these, 159 (21.0%) showed positive results for anti-HCV. Males, individuals in the 25 to 34 year age range, and individuals of lower economic levels were more likely to be seropositive for both viruses [prevalence rate (PR), 2.04; 95% confidence interval (95% CI), 1.43-2.92; p
doi_str_mv 10.3892/ijmm.21.3.387
format article
fullrecord <record><control><sourceid>crossref_spand</sourceid><recordid>TN_cdi_crossref_primary_10_3892_ijmm_21_3_387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3892_ijmm_21_3_387</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1137-d4e7727c331c17277499fdb87e1395f3d9221306e3d6e4ff3a0d54e5f8ed50753</originalsourceid><addsrcrecordid>eNpFkM1KAzEURoMoWKtL99nbtJNk0kyWWtQWCm60uBtiftqUmWRIpoK-jK9qaq2u7v3gfPfCAeAaF2NaCTJx27YdEzymOfITMMBcYETK8vU077jgiHI2PQcXKW2LgrBSVAPwdd85bVoXmrB2SjYj6Np2548RSq_hu4t_WW1klKo30aXeqTT6AbRLRiYDuxjW0aTkgofBwvlihfBkPlshFZDz1uSeVrCTvTO-T9DG0EIJU9j1GxM9vIvy0zVOetiFbtdkLPhLcGZlk8zV7xyCl4f759kcLZ8eF7PbJVIYU450aTgnXFGKFc4LL4Ww-q3iBlPBLNWCEEyLqaF6akprqSw0Kw2zldGs4IwOATrcVTGkFI2tu-haGT9qXNR7u_Xebk1wTXPkmb858KnLBpwO6b9wVJ0_7lHB6DccMH8C</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infectedc patients from a southern Brazilian population</title><source>Alma/SFX Local Collection</source><creator>Vissoci Reiche, Edna ; Bonametti, Ana ; Morimoto, Helena ; Morimoto, Arilson ; Wiechemann, Susana ; Matsuo, Tiemi ; Vissoci Reiche, Fernando ; Vogler, Ingridt</creator><creatorcontrib>Vissoci Reiche, Edna ; Bonametti, Ana ; Morimoto, Helena ; Morimoto, Arilson ; Wiechemann, Susana ; Matsuo, Tiemi ; Vissoci Reiche, Fernando ; Vogler, Ingridt</creatorcontrib><description>A cross-sectional study was carried out in order to describe the epidemiological, immunological and virological characteristics, and the disease progression of hepatitis C virus (HCV)/human immunodeficiency virus type 1 (HIV-1)- co-infected patients from a southern Brazilian population. Of 778 HIV-1-infected individuals enrolled in the study from September 2001 to December 2003, and followed up until June 2004, 757 were tested for anti-HCV antibodies. Of these, 159 (21.0%) showed positive results for anti-HCV. Males, individuals in the 25 to 34 year age range, and individuals of lower economic levels were more likely to be seropositive for both viruses [prevalence rate (PR), 2.04; 95% confidence interval (95% CI), 1.43-2.92; p&lt;0.001]. The anti-HCV reactivity was also associated with blood routes of transmission (PR, 2.20; 95% CI, 1.28-3.77; p&lt;0.001), intravenous drug use (PR, 5.79; 95% CI, 4.74-7.07; p&lt;0.001), self-reported previous sexually transmitted diseases (PR, 1.55; 95% CI, 1.18-2.04; p=0.002), VDRL positivity (PR, 2.87; 95% CI, 2.40-3.43; p&lt;0.001), and anti-HTLV I/II reactivity (PR, 5.09; 95% CI, 4.16-6.23; p&lt;0.001). In the follow-up period, the HCV/HIV-1-co-infected patients showed a trend toward lower CD4+ T-cell counts, higher HIV-1 RNA plasma viral load and faster disease progression than patients infected only with HIV-1, but significant differences were not observed. Although there were proportionately more deaths in the HCV/HIV-1-co-infected group, the use of highly active antiretroviral therapy (HAART) was a string predictor of increased CD4+ T-cell counts and decreased HIV-1 RNA plasma levels, suggesting that HAART is more important to the immunological and virological outcomes in HIV-1 infection than is HCV co-infection status.</description><identifier>ISSN: 1107-3756</identifier><identifier>EISSN: 1791-244X</identifier><identifier>DOI: 10.3892/ijmm.21.3.387</identifier><language>eng</language><publisher>D.A. Spandidos</publisher><ispartof>International journal of molecular medicine, 2008-03, Vol.21 (3), p.387-395</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Vissoci Reiche, Edna</creatorcontrib><creatorcontrib>Bonametti, Ana</creatorcontrib><creatorcontrib>Morimoto, Helena</creatorcontrib><creatorcontrib>Morimoto, Arilson</creatorcontrib><creatorcontrib>Wiechemann, Susana</creatorcontrib><creatorcontrib>Matsuo, Tiemi</creatorcontrib><creatorcontrib>Vissoci Reiche, Fernando</creatorcontrib><creatorcontrib>Vogler, Ingridt</creatorcontrib><title>Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infectedc patients from a southern Brazilian population</title><title>International journal of molecular medicine</title><description>A cross-sectional study was carried out in order to describe the epidemiological, immunological and virological characteristics, and the disease progression of hepatitis C virus (HCV)/human immunodeficiency virus type 1 (HIV-1)- co-infected patients from a southern Brazilian population. Of 778 HIV-1-infected individuals enrolled in the study from September 2001 to December 2003, and followed up until June 2004, 757 were tested for anti-HCV antibodies. Of these, 159 (21.0%) showed positive results for anti-HCV. Males, individuals in the 25 to 34 year age range, and individuals of lower economic levels were more likely to be seropositive for both viruses [prevalence rate (PR), 2.04; 95% confidence interval (95% CI), 1.43-2.92; p&lt;0.001]. The anti-HCV reactivity was also associated with blood routes of transmission (PR, 2.20; 95% CI, 1.28-3.77; p&lt;0.001), intravenous drug use (PR, 5.79; 95% CI, 4.74-7.07; p&lt;0.001), self-reported previous sexually transmitted diseases (PR, 1.55; 95% CI, 1.18-2.04; p=0.002), VDRL positivity (PR, 2.87; 95% CI, 2.40-3.43; p&lt;0.001), and anti-HTLV I/II reactivity (PR, 5.09; 95% CI, 4.16-6.23; p&lt;0.001). In the follow-up period, the HCV/HIV-1-co-infected patients showed a trend toward lower CD4+ T-cell counts, higher HIV-1 RNA plasma viral load and faster disease progression than patients infected only with HIV-1, but significant differences were not observed. Although there were proportionately more deaths in the HCV/HIV-1-co-infected group, the use of highly active antiretroviral therapy (HAART) was a string predictor of increased CD4+ T-cell counts and decreased HIV-1 RNA plasma levels, suggesting that HAART is more important to the immunological and virological outcomes in HIV-1 infection than is HCV co-infection status.</description><issn>1107-3756</issn><issn>1791-244X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpFkM1KAzEURoMoWKtL99nbtJNk0kyWWtQWCm60uBtiftqUmWRIpoK-jK9qaq2u7v3gfPfCAeAaF2NaCTJx27YdEzymOfITMMBcYETK8vU077jgiHI2PQcXKW2LgrBSVAPwdd85bVoXmrB2SjYj6Np2548RSq_hu4t_WW1klKo30aXeqTT6AbRLRiYDuxjW0aTkgofBwvlihfBkPlshFZDz1uSeVrCTvTO-T9DG0EIJU9j1GxM9vIvy0zVOetiFbtdkLPhLcGZlk8zV7xyCl4f759kcLZ8eF7PbJVIYU450aTgnXFGKFc4LL4Ww-q3iBlPBLNWCEEyLqaF6akprqSw0Kw2zldGs4IwOATrcVTGkFI2tu-haGT9qXNR7u_Xebk1wTXPkmb858KnLBpwO6b9wVJ0_7lHB6DccMH8C</recordid><startdate>200803</startdate><enddate>200803</enddate><creator>Vissoci Reiche, Edna</creator><creator>Bonametti, Ana</creator><creator>Morimoto, Helena</creator><creator>Morimoto, Arilson</creator><creator>Wiechemann, Susana</creator><creator>Matsuo, Tiemi</creator><creator>Vissoci Reiche, Fernando</creator><creator>Vogler, Ingridt</creator><general>D.A. Spandidos</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200803</creationdate><title>Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infectedc patients from a southern Brazilian population</title><author>Vissoci Reiche, Edna ; Bonametti, Ana ; Morimoto, Helena ; Morimoto, Arilson ; Wiechemann, Susana ; Matsuo, Tiemi ; Vissoci Reiche, Fernando ; Vogler, Ingridt</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1137-d4e7727c331c17277499fdb87e1395f3d9221306e3d6e4ff3a0d54e5f8ed50753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vissoci Reiche, Edna</creatorcontrib><creatorcontrib>Bonametti, Ana</creatorcontrib><creatorcontrib>Morimoto, Helena</creatorcontrib><creatorcontrib>Morimoto, Arilson</creatorcontrib><creatorcontrib>Wiechemann, Susana</creatorcontrib><creatorcontrib>Matsuo, Tiemi</creatorcontrib><creatorcontrib>Vissoci Reiche, Fernando</creatorcontrib><creatorcontrib>Vogler, Ingridt</creatorcontrib><collection>CrossRef</collection><jtitle>International journal of molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vissoci Reiche, Edna</au><au>Bonametti, Ana</au><au>Morimoto, Helena</au><au>Morimoto, Arilson</au><au>Wiechemann, Susana</au><au>Matsuo, Tiemi</au><au>Vissoci Reiche, Fernando</au><au>Vogler, Ingridt</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infectedc patients from a southern Brazilian population</atitle><jtitle>International journal of molecular medicine</jtitle><date>2008-03</date><risdate>2008</risdate><volume>21</volume><issue>3</issue><spage>387</spage><epage>395</epage><pages>387-395</pages><issn>1107-3756</issn><eissn>1791-244X</eissn><abstract>A cross-sectional study was carried out in order to describe the epidemiological, immunological and virological characteristics, and the disease progression of hepatitis C virus (HCV)/human immunodeficiency virus type 1 (HIV-1)- co-infected patients from a southern Brazilian population. Of 778 HIV-1-infected individuals enrolled in the study from September 2001 to December 2003, and followed up until June 2004, 757 were tested for anti-HCV antibodies. Of these, 159 (21.0%) showed positive results for anti-HCV. Males, individuals in the 25 to 34 year age range, and individuals of lower economic levels were more likely to be seropositive for both viruses [prevalence rate (PR), 2.04; 95% confidence interval (95% CI), 1.43-2.92; p&lt;0.001]. The anti-HCV reactivity was also associated with blood routes of transmission (PR, 2.20; 95% CI, 1.28-3.77; p&lt;0.001), intravenous drug use (PR, 5.79; 95% CI, 4.74-7.07; p&lt;0.001), self-reported previous sexually transmitted diseases (PR, 1.55; 95% CI, 1.18-2.04; p=0.002), VDRL positivity (PR, 2.87; 95% CI, 2.40-3.43; p&lt;0.001), and anti-HTLV I/II reactivity (PR, 5.09; 95% CI, 4.16-6.23; p&lt;0.001). In the follow-up period, the HCV/HIV-1-co-infected patients showed a trend toward lower CD4+ T-cell counts, higher HIV-1 RNA plasma viral load and faster disease progression than patients infected only with HIV-1, but significant differences were not observed. Although there were proportionately more deaths in the HCV/HIV-1-co-infected group, the use of highly active antiretroviral therapy (HAART) was a string predictor of increased CD4+ T-cell counts and decreased HIV-1 RNA plasma levels, suggesting that HAART is more important to the immunological and virological outcomes in HIV-1 infection than is HCV co-infection status.</abstract><pub>D.A. Spandidos</pub><doi>10.3892/ijmm.21.3.387</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1107-3756
ispartof International journal of molecular medicine, 2008-03, Vol.21 (3), p.387-395
issn 1107-3756
1791-244X
language eng
recordid cdi_crossref_primary_10_3892_ijmm_21_3_387
source Alma/SFX Local Collection
title Epidemiological, immunological and virological characteristics, and disease progression of HIV-1/HCV-co-infectedc patients from a southern Brazilian population
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T04%3A30%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref_spand&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidemiological,%20immunological%20and%20virological%20characteristics,%20and%20disease%20progression%20of%20HIV-1/HCV-co-infectedc%20patients%20from%20a%20southern%20Brazilian%20population&rft.jtitle=International%20journal%20of%20molecular%20medicine&rft.au=Vissoci%20Reiche,%20Edna&rft.date=2008-03&rft.volume=21&rft.issue=3&rft.spage=387&rft.epage=395&rft.pages=387-395&rft.issn=1107-3756&rft.eissn=1791-244X&rft_id=info:doi/10.3892/ijmm.21.3.387&rft_dat=%3Ccrossref_spand%3E10_3892_ijmm_21_3_387%3C/crossref_spand%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1137-d4e7727c331c17277499fdb87e1395f3d9221306e3d6e4ff3a0d54e5f8ed50753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true